Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE).
about
Poxvirus vectors as HIV/AIDS vaccines in humansThe evolution of poxvirus vaccinesDirectly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trialPrescription medication misuse among HIV-infected individuals taking antiretroviral therapyUse of HIV primary care by HIV-positive Haitian immigrants in Miami, FloridaDirectly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection.Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or PolyphosphazenePoly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.HIV epidemic in Asia: optimizing and expanding vaccine development.Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infectionRational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.Development and field testing of an HIV medication touch screen computer patient adherence tool with telephone-based, targeted adherence counseling.Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys.The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.
P2860
Q26995078-C494091C-50F4-4144-BFF6-2C53261733F0Q26995905-6F3AC928-9300-4A18-91F4-72EC2C50A195Q30497684-FA9B1F5A-441C-450D-A418-82159F975EDDQ34602717-A1714A91-62F3-4E3F-A63B-7886450A43ABQ34806434-2EEF9D45-0D72-463B-BC0F-245F58FDABBEQ35633045-31CCD985-ED8D-45CB-B737-0233BBFD69EFQ35826728-0F266886-7B54-450A-90CC-13680744C21DQ35878653-0B042CCF-6846-43FC-A513-A6B47B7942C9Q36931790-6EFE3F7D-734C-412C-BA75-D02C80B4A932Q37404708-7BB4879A-6CC9-4510-BDF0-BCEE4EC5C60BQ37785947-E5156AB4-EDAA-49C3-BEB5-8D60D4D4A70DQ37785949-3544F0DD-7DCD-4152-AB6B-E084602B2B62Q38036687-F94E39D3-E7FA-4A5B-B909-9B707F353D6FQ40030804-10E68961-2820-44C4-B393-DB328B9FAC8CQ42386442-ACC434F3-C503-4E79-8485-B22ADFC7A48BQ42411962-F9BDABB2-7055-4AD7-9B0A-FA9ACA31DB94Q44208445-DB9F3873-9EE8-409F-88C4-2393B1DDE418Q45888470-C05FBF7A-E74D-484B-BEDF-7769D01A3818Q48242815-0E9148C1-245F-45F4-93A1-35A74ED7ED98
P2860
Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@en
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@nl
type
label
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@en
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@nl
prefLabel
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@en
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@nl
P2093
P1476
Acceptability of A-CASI by HIV ...... vioral intervention (INSPIRE).
@en
P2093
INSPIRE Study Team
Julia H Arnsten
Karin E Tobin
Lisa R Metsch
Sonja Mackenzie
Toni Wunch
Yuko Mizuno
P304
P356
10.1097/QAI.0B013E3181576795
P407
P478
46 Suppl 2
P577
2007-11-01T00:00:00Z